VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
YB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
YBYuanbao Inc. American Depositary Shares
$15.45$119M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksYBQuarterly Financials

Yuanbao Inc. American Depositary Shares (YB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Yuanbao Inc. American Depositary Shares (YB) quarterly income statement — complete revenue, gross profit & net income history

YB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q4'23Q3'23Q4'22
Revenue1.16B1.07B970.06M888.76M866.78M544.07M537.54M343.52M
Revenue Growth %33.59%--63.35%61.25%58.38%--
Medical Costs & Claims45.07M40.9M44.76M42.58M44.63M39.42M31.77M23.25M
Medical Cost Ratio %3.89%3.82%4.61%4.79%5.15%7.24%5.91%6.77%
Gross Profit1.11B1.03B925.3M846.18M822.14M504.65M505.77M320.27M
Gross Margin %96.11%96.18%95.39%95.21%94.85%92.76%94.09%93.23%
Gross Profit Growth %35.36%--67.68%62.55%57.57%--
Operating Expenses758.3M731.29M635.89M556.97M567.57M422.57M466.52M309.95M
OpEx / Revenue %65.49%68.35%65.55%62.67%65.48%77.67%86.79%90.23%
Depreciation & Amortization724.75K724.75K724.75K3.87M3.73M2.62M5.86M2.27M
Combined Ratio %69.38%72.17%70.17%67.46%70.63%84.91%92.7%96.99%
Operating Income354.54M297.73M289.41M289.21M254.57M82.08M39.24M10.32M
Operating Margin %30.62%27.83%29.83%32.54%29.37%15.09%7.3%3.01%
Operating Income Growth %39.27%--252.35%548.74%695.12%--
EBITDA355.26M298.46M290.14M293.08M258.3M84.7M45.1M12.59M
EBITDA Margin %30.68%27.9%29.91%32.98%29.8%15.57%8.39%3.66%
Interest Expense00000000
Non-Operating Income00000000
Pretax Income378.27M315.81M301.82M301.33M261.32M89.37M43.5M13.43M
Pretax Margin %32.67%29.52%31.11%33.91%30.15%16.43%8.09%3.91%
Income Tax7.91M11.12M6.72M9.04M16.49M152K54K12K
Effective Tax Rate %2.09%3.52%2.23%3%6.31%0.17%0.12%0.09%
Net Income370.36M304.69M295.1M292.3M244.84M60.8M64.24M13.94M
Net Margin %31.99%28.48%30.42%32.89%28.25%11.17%11.95%4.06%
Net Income Growth %51.27%--380.76%281.15%336.09%--
EPS (Diluted)46.07125.5542.1183.20-11.70-16.38-8.28-21.72
EPS Growth %493.76%--607.94%-41.3%24.59%--
EPS (Basic)49.37164.1342.1183.20-11.70-16.38-8.28-21.72
Diluted Shares Outstanding8.05M7.84M7.51M7.51M7.51M7.51M7.51M7.51M